NaranjoCABustoUSellersEMSandorPRuizIRobertsEAA method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981;30:239–45.
2.
GoughHGogginTBissessarABakerMCrowleyMCallaghanN. A comparative study of the influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q J Med1986;59: 569–77.
3.
ZerwekhJEHomanRTindallRPakCY. Decreased serum 24,25-dihydroxyvitamin D concentration during long-term anticonvulsant therapy in adult epileptics. Ann Neurol1982;12: 184–6.
4.
TjellesenLChristiansenC. Serum vitamin D metabolites in epileptic patients treated with 2 different anticonvulsants. Acta Neurol Scand1982;66: 335–41.
5.
PluskiewiczWNowakowskaJ. Bone status after long-term anticonvulsant therapy in epileptic patients: Evaluation using quantitative ultrasound of calcaneus and phalanges. Ultrasound Med Biol1997;23: 553–8.
6.
TjellesenLGotfredsenABorgJChristiansenC. Relationship between local and total body bone mineral in epileptic patients and normal subjects. Clin Physiol1983;3: 359–64.
7.
DymlingJFLidgrenLWalloeA. Biochemical variables related to calcium metabolism in epileptics. Acta Med Scand1979;205: 401–4.